1. Home
  2. XIN vs MRNS Comparison

XIN vs MRNS Comparison

Compare XIN & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XIN
  • MRNS
  • Stock Information
  • Founded
  • XIN 1997
  • MRNS 2003
  • Country
  • XIN China
  • MRNS United States
  • Employees
  • XIN N/A
  • MRNS N/A
  • Industry
  • XIN Homebuilding
  • MRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • XIN Consumer Discretionary
  • MRNS Health Care
  • Exchange
  • XIN Nasdaq
  • MRNS Nasdaq
  • Market Cap
  • XIN 15.9M
  • MRNS 15.1M
  • IPO Year
  • XIN N/A
  • MRNS 2014
  • Fundamental
  • Price
  • XIN $2.41
  • MRNS $0.27
  • Analyst Decision
  • XIN
  • MRNS Buy
  • Analyst Count
  • XIN 0
  • MRNS 12
  • Target Price
  • XIN N/A
  • MRNS $4.28
  • AVG Volume (30 Days)
  • XIN 28.3K
  • MRNS 1.0M
  • Earning Date
  • XIN 01-01-0001
  • MRNS 11-12-2024
  • Dividend Yield
  • XIN N/A
  • MRNS N/A
  • EPS Growth
  • XIN N/A
  • MRNS N/A
  • EPS
  • XIN N/A
  • MRNS N/A
  • Revenue
  • XIN $667,143,185.00
  • MRNS $31,466,000.00
  • Revenue This Year
  • XIN N/A
  • MRNS $13.90
  • Revenue Next Year
  • XIN N/A
  • MRNS $44.00
  • P/E Ratio
  • XIN $0.27
  • MRNS N/A
  • Revenue Growth
  • XIN N/A
  • MRNS 1.63
  • 52 Week Low
  • XIN $1.92
  • MRNS $0.22
  • 52 Week High
  • XIN $7.05
  • MRNS $11.26
  • Technical
  • Relative Strength Index (RSI)
  • XIN 33.59
  • MRNS 37.42
  • Support Level
  • XIN $2.24
  • MRNS $0.22
  • Resistance Level
  • XIN $2.59
  • MRNS $0.26
  • Average True Range (ATR)
  • XIN 0.25
  • MRNS 0.02
  • MACD
  • XIN -0.02
  • MRNS 0.02
  • Stochastic Oscillator
  • XIN 10.34
  • MRNS 68.13

About XIN Xinyuan Real Estate Co Ltd

Xinyuan Real Estate Co Ltd operates as a real estate developer and property manager in China. It focuses on developing residential projects, which typically consist of multiple residential buildings that include multi-layer apartment buildings, and others. Its several projects include auxiliary services and amenities such as retail outlets, leisure and health facilities, kindergartens, and schools. It aims to provide comfortable and convenient real estate-related products and services to middle-class consumers.

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

Share on Social Networks: